6JC2
Crystal structure of the Fab fragment of ipilimumab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PAL/PLS BEAMLINE 7A (6B, 6C1) |
Synchrotron site | PAL/PLS |
Beamline | 7A (6B, 6C1) |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2018-01-24 |
Detector | ADSC QUANTUM 270 |
Wavelength(s) | 1 |
Spacegroup name | P 43 21 2 |
Unit cell lengths | 119.614, 119.614, 82.597 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 30.785 - 2.650 |
R-factor | 0.2051 |
Rwork | 0.202 |
R-free | 0.26250 |
Structure solution method | MOLECULAR REPLACEMENT |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX (1.13_2998) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 30.800 | 2.700 |
High resolution limit [Å] | 2.650 | 2.650 |
Number of reflections | 17797 | |
<I/σ(I)> | 24.5 | |
Completeness [%] | 99.3 | |
Redundancy | 7.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 20% PEG 10000, 0.2M ammonium sulfate, 0.1M Acetate pH5.0 |